Medical Communications
Gilead to work with Genmab on HIV targeting technology
August 12, 2016 Medical Communications, Research and Development, Sales and Marketing Genmab, Gilead, HIV, duobody
Thousands to benefit with new anti-clotting drug recommendation, says NICE
August 12, 2016 Medical Communications, Sales and Marketing AstraZeneca, Brilique, ticagrelor
Valeant under criminal investigation
August 11, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Philidor, Valeant, investigation
Chronos Therapetics strengthens management with two new vice presidents
August 10, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
New senior VP, finance at Eli Lilly
August 10, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly
New Agilent expansion will ‘more than double’ nucleic acid API manufacture
August 10, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Agilent, expansion, manufacturing, oligonucleotide
Apellis Pharmaceuticals appoints Dr Robert Kim as CMO
August 8, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Apellis, CMO, GSK, Novartis, appointment
The power of PrEP
August 8, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, PrEP, high court, lifestyle drug
Top ten stories in the pharmaceutical industry this week
August 5, 2016 Medical Communications, Research and Development Actavis, Bioelectronics, CDF, Celgne, EMA, GSK, GlaxoSmithKline, Innovate UK, Medivation, NICE, Novartis, Roche, Sanofi, Teva, appointments, apremilast, biog, breast cancer, brexit, google, pharmaceutical industry, rheumatoid arthritis, sarilumab, top ten
Novo Nordisk diabetes drug Victoza fails to reduce heart failure risk
August 5, 2016 Medical Communications, Research and Development Eli Lily, Novo Nordisk, Victoza, diabetes, heart failure
Majority of US patients’ groups supporting pharma against Medicare reforms received industry funding, claims report
August 5, 2016 Medical Communications, Research and Development medicare reform, patients' groups, public citizen
Eylea sales jump helps boost Regeneron in Q2 results
August 5, 2016 Medical Communications, Research and Development 2016, Eylea, Q2, Regeneron, results
Merck Q2 results beat analyst estimates
August 4, 2016 Medical Communications, Sales and Marketing Merck, financial results
FDA determines Xiamen Origin Biotech wilfully lied to inspectors and customers
August 4, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Xiamen Origin Biotech
Joint Article on Hydrogen Peroxide Efficacy Published in Letters in Applied Microbiology
August 2, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wickham laboratories
Latest content
MedPharm appoints Jason Mieding as chief operating officer
Coriolis Pharma appoints Teun van der Heide as CEO
The evidence bar impacting UK medical cannabis access
